Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Present And Forecasted Size Of The Autoimmune Treatment Market?
Recently, the autoimmune treatment market has experienced significant expansion. It is predicted to increase from $7.72 billion in 2024 to $8.63 billion in 2025, with a compound annual growth rate (CAGR) of 11.7%. Facets such as a rise in prevalence, progress in immunology and genetic research, enhanced patient knowledge and engagement, along with regulatory assistance, have contributed to the growth witnessed in the historic period.
There is an anticipated swift expansion in the autoimmune treatment market size in the forthcoming years, with projections indicating a growth to $14.54 billion in 2029, featuring a compound annual growth rate (CAGR) of 13.9%. Factors contributing to this predicted growth within the forecast period include the advent of precision medicine, the development of small molecule therapies, novel pathways targeting, advancements in gene therapy, increased biopharmaceutical investments, and progress in the biosimilar market. Significant trends expected to be seen in this period include progress in biologics and targeted therapies, immunomodulatory therapies, increased attention to rare autoimmune diseases, the rise of telemedicine and remote monitoring, regulatory endeavors and drug approvals, along with the incorporation of digital health tools.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp
What Drivers Are Accelerating Expansion Of The Autoimmune Treatment Market?
The surge in funding for the research and development of autoimmune disease medications are projected to fuel the expansion of the autoimmune treatment market. The process of research and development involves businesses investing time and resources into creating novel goods and services. The investigation and development of pharmaceuticals for autoimmune conditions lead to the creation of more specific, light-weight molecule, orally consumable, and chemically classified immune suppressive drugs that are tolerable long-term for autoimmune disease patients. As an example, Eli Lilly and Company, an American pharmaceutical firm, elevated their research and development investment from $7 billion in 2021 to $7.19 billion in 2022. This led to an increase in the company’s R&D expenditure as a percentage of their revenue from 24.8% to 25.19%. Hence, this escalation in investments in drug research and development propels the growth of the autoimmune treatment market.
What Are The Primary Segmentation Parameters In The Autoimmune Treatment Market?
The autoimmune treatmentmarket covered in this report is segmented –
1) By Product: Consumables And Assay Kits; Instruments; Services
2) By Service Type: Consultation And Diagnosis; Therapy And monitoring; Drug development
3) By Disease: Rheumatoid Arthritis; Systemic Lupus Erythematosus; Sjögren’s Syndrome; Thyroiditis; Scleroderma; Other Diseases
4) By Drug Class: Anti-Inflammatory; Anti-Hyperglycemic; NSAIDs; Interferons; Other Drug Class
Subsegments:
1) By Consumables And Assay Kits: ELISA Kits; Reagents And Antibodies; Sample Collection Kits
2) By Instruments: Diagnostic Equipment; Imaging Systems
3) By Services: Testing And Diagnostics Services; Consultation And Support Services; Data Analysis And Interpretation Services
How Are Industry Trends Steering The Expansion Of The Autoimmune Treatment Market?
Advancements in technology are emerging as an influential trend within the autoimmune treatment market. Key players in this market are focusing on introducing cutting-edge technologies in a bid to maintain their dominance. To illustrate, UCB, a pharmaceutical establishment based in Belgium, was given the green light by the U.S. Food and Drug Administration (FDA), in June 2023, for its product RYSTIGGO (rozanolixizumab-noli), meant for treating generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies. The approval process was expedited under Priority Review. RYSTIGGO is currently the single therapy approved by the FDA for both anti-AchR and anti-MuSK antibody-positive gMG, which covers the two most common types of this condition. Therefore it holds potential to heighten provider effectiveness, increase treatment success and deliver higher quality patient care.
Which Players Are Shaping The Competitive Landscape Of The Autoimmune Treatment Market?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation PLC, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
What Are The Emerging Regional Trends Driving The Autoimmune Treatment Market?
North America was the largest region in the autoimmune treatment market in 2024. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp
Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2025, By The Business Research Company
Autoimmune Disease Diagnosis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Benign Prostatic Hyperplasia Bph Treatment Devices And Equipment Global Market Report 2025
Fertility Treatments Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model